Correction: Myeloid Suppressor Cell Depletion Augments Antitumor Activity in Lung Cancer

Correction: Myeloid Suppressor Cell Depletion Augments Antitumor Activity in Lung Cancer

Bibliographic Details
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2012-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3484161/?tool=EBI

Similar Items

Targeting TREM1 augments antitumor T cell immunity by inhibiting myeloid-derived suppressor cells and restraining anti–PD-1 resistance
by: Ashwin Ajith, et al.
Published: (2023-11-01)

Regulation of T cells by myeloid-derived suppressor cells: emerging immunosuppressor in lung cancer
by: Zhong-Ning He, et al.
Published: (2023-10-01)

Myeloid-derived suppressor cells and associated events in urethane-induced lung cancer
by: Daniela Teixeira, et al.
Published: (2013-06-01)

Targeting depletion of myeloid-derived suppressor cells potentiates PD-L1 blockade efficacy in gastric and colon cancers
by: Yao Tang, et al.
Published: (2022-12-01)

Myeloid-Derived Suppressor Cells in Colorectal Cancer
by: Izabela Sieminska, et al.
Published: (2020-08-01)

Myeloid-Derived Suppressor Cells Specifically Suppress IFN-γ Production and Antitumor Cytotoxic Activity of Vδ2 T Cells
by: Alessandra Sacchi, et al.
Published: (2018-06-01)

LAL deficiency induced myeloid-derived suppressor cells as targets and biomarkers for lung cancer
by: Sheng Liu, et al.
Published: (2023-03-01)

NAMPT-targeting PROTAC promotes antitumor immunity via suppressing myeloid-derived suppressor cell expansion
by: Ying Wu, et al.
Published: (2022-06-01)

Research Progress of Granulocytic Myeloid-derived Suppressor Cells  in Non-small Cell Lung Cancer
by: Chaodan YANG, et al.
Published: (2024-01-01)

Advances in the study of myeloid-derived suppressor cells in infectious lung diseases
by: Meng-Nan Zhang, et al.
Published: (2023-03-01)

Targeting Myeloid-Derived Suppressor Cells in Ovarian Cancer
by: Seiji Mabuchi, et al.
Published: (2021-02-01)

Targeting Myeloid-Derived Suppressor Cells in Cancer Immunotherapy
by: Yufei Wang, et al.
Published: (2020-09-01)

The role of myeloid-derived suppressor cells in liver cancer
by: Shiyue Zhou, et al.
Published: (2023-05-01)

LncRNAs has been identified as regulators of Myeloid-derived suppressor cells in lung cancer
by: Yifan Liu, et al.
Published: (2023-02-01)

Myeloid-Derived Suppressor Cells: Therapeutic Target for Gastrointestinal Cancers
by: Junaid Arshad, et al.
Published: (2024-03-01)

Immunosuppressive Effects of Myeloid-Derived Suppressor Cells in Cancer and Immunotherapy
by: Mithunah Krishnamoorthy, et al.
Published: (2021-05-01)

Metabolic Regulation of Myeloid-Derived Suppressor Cell Function in Cancer
by: Yufei Wang, et al.
Published: (2020-04-01)

The Role of Myeloid-Derived Suppressor Cells in the Treatment of Pancreatic Cancer
by: Peng Dong MM, et al.
Published: (2022-12-01)

Myeloid-Derived Suppressor Cells as a Therapeutic Target for Cancer
by: Andrew M. K. Law, et al.
Published: (2020-02-01)

The Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer Progression
by: Viktor Umansky, et al.
Published: (2016-11-01)

Role of myeloid-derived suppressor cells in hormone-dependent cancers
by: Siddhartha Mukherjee, et al.
Published: (2021-03-01)

Understanding the Differentiation, Expansion, Recruitment and Suppressive Activities of Myeloid-Derived Suppressor Cells in Cancers
by: Hui Xuan Lim, et al.
Published: (2020-05-01)

Selective depletion of polymorphonuclear myeloid derived suppressor cells in tumor beds with near infrared photoimmunotherapy enhances host immune response
by: Takuya Kato, et al.
Published: (2022-12-01)

MCL1 inhibition targets Myeloid Derived Suppressors Cells, promotes antitumor immunity and enhances the efficacy of immune checkpoint blockade
by: Nabanita Mukherjee, et al.
Published: (2024-03-01)

3,3′-Diindolylmethane improves antitumor immune responses of PD-1 blockade via inhibiting myeloid-derived suppressor cells
by: Qi Sun, et al.
Published: (2022-06-01)

Myeloid-Derived Suppressor Cells in Solid Tumors
by: Tianmiao Ma, et al.
Published: (2022-01-01)

Myeloid-Derived Suppressor Cells (MDSCs) in Haematology
by: Nikoleta Bizymi, et al.
Published: (2021-12-01)

Myeloid-derived suppressor cells and pulmonary hypertension
by: Hui Zhang, et al.
Published: (2023-06-01)

Dexmedetomidine expands monocytic myeloid-derived suppressor cells and promotes tumour metastasis after lung cancer surgery
by: Xiaosan Su, et al.
Published: (2018-12-01)

Myeloid-Derived Suppressor Cells and Mesenchymal Stem/Stromal Cells in Myeloid Malignancies
by: Suncica Kapor, et al.
Published: (2021-06-01)

CD115− monocytic myeloid-derived suppressor cells are precursors of OLFM4high polymorphonuclear myeloid-derived suppressor cells
by: Yunyun Zou, et al.
Published: (2023-03-01)

Evolution and Targeting of Myeloid Suppressor Cells in Cancer: A Translational Perspective
by: Augusto Bleve, et al.
Published: (2022-01-01)

Editorial: Myeloid-derived suppressor cells in inflammation and its complications and cancers
by: Xing Li, et al.
Published: (2023-07-01)

The effect of adoptive transferring myeloid-derived suppressor cells in ventilator-induced lung injury mice
by: Fangzhen Shan, et al.
Published: (2024-02-01)

Role of myeloid-derived suppressor cells in chronic brucellosis
by: Shuiping Hou, et al.
Published: (2024-01-01)

The Roles of Myeloid-Derived Suppressor Cells in Liver Disease
by: Chunye Zhang, et al.
Published: (2024-01-01)

Decoding the Myeloid-Derived Suppressor Cells in Lymphoid Malignancies
by: Iosif Papafragkos, et al.
Published: (2021-08-01)

The role of myeloid derived suppressor cells in musculoskeletal disorders
by: Yi Ren, et al.
Published: (2023-03-01)

Myeloid-Derived Suppressor Cells: Ductile Targets in Disease
by: Francesca Maria Consonni, et al.
Published: (2019-05-01)

The Emerging Role of Myeloid-Derived Suppressor Cells in Tuberculosis
by: Tandeka Magcwebeba, et al.
Published: (2019-04-01)